13F filer · CIK 1418329 ↗

Ninety One UK Ltd

You are looking at Q4 2019. See the latest, Q3 2026 →

Reported value

$30.15B

+17% on the quarter before

Positions

238

33 new · 30 sold out

Top 10

32.6%

of the value

Est. gain

+$2.40B

on stocks held all quarter

Est. return

+10.8%

on those stocks since Q3 2019

Filed

Feb 7, 2020

On SEC EDGAR ↗

Positions as of Dec 31, 2019, from Ninety One UK Ltd's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

New
Added
Cut
Same
Options

The 24 largest positions, 52% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2019. Striped tiles are options.

Microsoft6.5%Alibaba5.7%

Booking Holdings Inc3.8%

Visa Inc.3.7%Alphabet2.6%

Citigroup Inc2.5%

Johnson & Johnson2.3%

Moody's Corporation2.0%

Verisign Inc2.0%

Netease Inc1.7%

Medtronic Plc1.6%

Philip Morris International In1.6%

S&P Global Inc1.6%

Meta1.6%Apple1.6%

Thermo Fisher Scientific Inc1.5%

Charles Schwab Corp/The1.5%

Mastercard1.4%

Becton Dickinson And Co1.3%

Fidelity National Information1.3%

Unitedhealth Group Inc1.2%

Honeywell Technologies1.2%

Bank Of America Corp1.2%

Intuit1.2%

Microsoft6.5%Alibaba5.7%

Booking Holdings Inc3.8%

Visa Inc.3.7%Alphabet2.6%

Citigroup Inc2.5%

Johnson & Johnson2.3%

Moody's Corporation2.0%

Verisign Inc2.0%

Netease Inc1.7%

Medtronic Plc1.6%

Philip Morris International In1.6%

S&P Global Inc1.6%

Meta1.6%Apple1.6%

Thermo Fisher Scientific Inc1.5%

Charles Schwab Corp/The1.5%

Mastercard1.4%

Becton Dickinson And Co1.3%

Fidelity National Information1.3%

Unitedhealth Group Inc1.2%

Honeywell Technologies1.2%

Bank Of America Corp1.2%

Intuit1.2%

Largest buys

Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Medtronic Plc~$495.0MNew · 0.0% → 1.6%+4,363,036 shares
Nxp Semiconductor Nv~$313.0MNew · 0.0% → 1.0%+2,459,298 shares
Check Point Software Technolog~$299.9MNew · 0.0% → 1.0%+2,702,596 shares
Ingersoll-Rand Plc~$296.1MNew · 0.0% → 1.0%+2,227,328 shares
Netease Inc~$275.4MAdded · 0.8% → 1.7%+898,188 shares
Coca-Cola European Partners Pl~$218.9MNew · 0.0% → 0.7%+4,301,460 shares
State Street Corp~$206.4MNew · 0.0% → 0.7%+2,609,233 shares
Broadcom~$172.4MAdded · 0.5% → 1.1%+545,500 shares
Visa Inc.~$151.8MAdded · 3.4% → 3.7%+808,021 shares
Delphi Technologies Plc~$142.6MNew · 0.0% → 0.5%+11,114,561 shares

Largest sells

Since Q3 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Infosys Ltd~$431.4MSold out · 1.7% → 0.0%−37,939,420 shares
PayPal~$410.8MCut · 1.6% → 0.0%−3,797,871 shares
Comcast Corp~$391.1MCut · 1.5% → 0.0%−8,697,310 shares
Chevron Corp~$257.1MCut · 1.0% → 0.0%−2,133,451 shares
Amazon~$180.0MCut · 1.5% → 0.8%−97,412 shares
Eli Lilly~$174.1MCut · 0.6% → 0.0%−1,324,282 shares
Norfolk Southern Corp~$153.4MSold out · 0.6% → 0.0%−853,578 shares
Cbs Corp~$152.1MSold out · 0.6% → 0.0%−3,766,816 shares
Unum Group~$107.3MSold out · 0.4% → 0.0%−3,611,342 shares
Dell Technologies Inc~$98.3MSold out · 0.4% → 0.0%−1,895,622 shares

Holdings

As of Dec 31, 2019. Changes are in shares against Sep 30, 2019, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
#	Holding		% prev	Value	Shares		Price	Prev price
1	MicrosoftCommon Stock · shares +7.0% · price +13.4%	6.5%	6.3%	$1.97B	12.5M	+7.0%	$157.70	$139.03	+13.4%	+$218.0M
2	AlibabaADR · shares +2.3% · price +26.8%	5.7%	5.1%	$1.71B	8.1M	+2.3%	$212.10	$167.23	+26.8%	+$354.2M
3	Booking Holdings IncCommon Stock · shares +9.0% · price +4.6%	3.8%	3.9%	$1.15B	559,169	+9.0%	$2,053.73	$1,962.61	+4.6%	+$46.8M
4	Visa Inc.Common Stock · shares +16% · price +9.2%	3.7%	3.4%	$1.10B	5.9M	+16%	$187.90	$172.01	+9.2%	+$80.5M
5	AlphabetCommon Stock · shares −1.1% · price +9.7%	2.6%	2.8%	$769.4M	574,459	−1.1%	$1,339.39	$1,221.14	+9.7%	+$67.9M
6	Citigroup IncCommon Stock · shares +9.6% · price +15.6%	2.5%	2.3%	$741.4M	9.3M	+9.6%	$79.89	$69.08	+15.6%	+$91.5M
7	Johnson & JohnsonCommon Stock · shares +8.2% · price +12.7%	2.3%	2.2%	$690.0M	4.7M	+8.2%	$145.87	$129.38	+12.7%	+$72.1M
8	Moody's CorporationCommon Stock · shares +19% · price +15.9%	2.0%	1.7%	$598.6M	2.5M	+19%	$237.41	$204.83	+15.9%	+$69.3M
9	Verisign IncCommon Stock · shares +18% · price +2.1%	2.0%	1.9%	$592.7M	3.1M	+18%	$192.68	$188.63	+2.1%	+$10.6M
10	Netease IncADR · shares +114% · price +15.2%	1.7%	0.81%	$516.4M	1.7M	+114%	$306.64	$266.18	+15.2%	+$31.8M
11	Medtronic PlcCommon Stock · shares New	1.6%	—	$495.0M	4.4M	New	$113.45	—	—	—
12	Philip Morris International InCommon Stock · shares +15% · price +12.1%	1.6%	1.5%	$495.0M	5.8M	+15%	$85.09	$75.93	+12.1%	+$46.2M
13	S&P Global IncCommon Stock · shares +3.8% · price +11.5%	1.6%	1.7%	$494.4M	1.8M	+3.8%	$273.05	$244.98	+11.5%	+$49.0M
14	MetaCommon Stock · shares −1.9% · price +15.3%	1.6%	1.7%	$481.1M	2.3M	−1.9%	$205.25	$178.08	+15.3%	+$63.7M
15	AppleCommon Stock · shares −4.3% · price +31.1%	1.6%	1.5%	$468.9M	1.6M	−4.3%	$293.65	$223.97	+31.1%	+$111.3M
16	Thermo Fisher Scientific IncCommon Stock · shares −4.1% · price +11.5%	1.5%	1.7%	$456.2M	1.4M	−4.1%	$324.87	$291.27	+11.5%	+$47.2M
17	Charles Schwab Corp/TheCommon Stock · shares +18% · price +13.7%	1.5%	1.3%	$453.7M	9.5M	+18%	$47.56	$41.83	+13.7%	+$46.2M
18	MastercardCommon Stock · shares −2.9% · price +9.9%	1.4%	1.5%	$410.8M	1.4M	−2.9%	$298.59	$271.57	+9.9%	+$37.2M
19	Becton Dickinson And CoCommon Stock · shares +14% · price +7.5%	1.3%	1.2%	$382.6M	1.4M	+14%	$271.97	$252.96	+7.5%	+$23.5M
20	Fidelity National InformationCommon Stock · shares +20% · price +4.8%	1.3%	1.2%	$379.3M	2.7M	+20%	$139.09	$132.76	+4.8%	+$14.4M
21	Unitedhealth Group IncCommon Stock · shares −1.5% · price +35.3%	1.2%	1.1%	$370.6M	1.3M	−1.5%	$293.98	$217.32	+35.3%	+$96.6M
22	Honeywell TechnologiesCommon Stock · shares −5.8% · price +4.6%	1.2%	1.4%	$365.2M	2.1M	−5.8%	$177.00	$169.20	+4.6%	+$16.1M
23	Bank Of America CorpCommon Stock · shares +39% · price +20.7%	1.2%	0.84%	$360.5M	10.2M	+39%	$35.22	$29.17	+20.7%	+$44.6M
24	IntuitCommon Stock · shares +19% · price −1.5%	1.2%	1.2%	$352.2M	1.3M	+19%	$261.93	$265.94	−1.5%	−$4.5M
25	Merck & Co IncCommon Stock · shares −3.2% · price +8.0%	1.2%	1.3%	$351.6M	3.9M	−3.2%	$90.95	$84.18	+8.0%	+$26.2M
	Total · 238 positions	100%		$30.15B						+$2.40B

The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q3 2019 to Q4 2019: 205 stocks held throughout, up $2.40B (+10.8%).

Alibaba+$354.2M+27%
Microsoft+$218.0M+13%
Apple+$111.3M+31%
Unitedhealth Group Inc+$96.6M+35%
Citigroup Inc+$91.5M+16%
Ally Financial Inc−$6.8M−8%
Resideo Technologies Inc−$9.9M−17%
Ebay Inc−$12.8M−7%
Anheuser-Busch Inbev Sa/Nv−$13.4M−14%
Amc Networks Inc−$22.5M−20%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$100.00B$50.00B$0

Q1 201643 quartersQ3 2026

Every quarter's filing

Each quarter's 13F filing, newest first
Quarter	Filed	Reported value	Positions	Filing
Q3 2026	Oct 15, 2026	$45.47B+2%	331	SEC ↗
Q2 2026	Jul 16, 2026	$44.73B+4%	271	SEC ↗
Q1 2026	Apr 24, 2026	$43.13B−8%	237	SEC ↗
Q4 2025	Jan 27, 2026	$46.64B−49%	225	SEC ↗
Q3 2025	Oct 21, 2025 (amended)	$91.76B+115%	210	SEC ↗
Q2 2025	Jul 18, 2025	$42.61B+19%	202	SEC ↗
Q1 2025	Apr 30, 2025	$35.94B−4%	193	SEC ↗
Q4 2024	Jan 27, 2025	$37.38B−0%	191	SEC ↗
Q3 2024	Nov 12, 2024	$37.47B+3%	194	SEC ↗
Q2 2024	Jul 22, 2024	$36.22B+2%	187	SEC ↗
Q1 2024	Apr 25, 2024	$35.61B+6%	185	SEC ↗
Q4 2023	Jan 31, 2024	$33.61B+6%	178	SEC ↗
Q3 2023	Oct 10, 2023	$31.62B−8%	177	SEC ↗
Q2 2023	Jul 19, 2023	$34.27B+7%	183	SEC ↗
Q1 2023	Apr 28, 2023	$32.10B+3%	180	SEC ↗
Q4 2022	Feb 7, 2023	$31.19B+3%	187	SEC ↗
Q3 2022	Nov 14, 2022	$30.32B−10%	190	SEC ↗
Q2 2022	Aug 15, 2022	$33.63B−14%	190	SEC ↗
Q1 2022	May 26, 2022	$39.26B−7%	196	SEC ↗
Q4 2021	Feb 11, 2022	$42.13B+8%	208	SEC ↗
Q3 2021	Nov 2, 2021	$39.16B+1%	208	SEC ↗
Q2 2021	Aug 12, 2021	$38.59B+10%	209	SEC ↗
Q1 2021	May 7, 2021	$35.18B+8%	215	SEC ↗
Q4 2020	Feb 5, 2021	$32.51B+18%	219	SEC ↗
Q3 2020	Nov 12, 2020	$27.65B−2%	223	SEC ↗
Q2 2020	Sep 4, 2020 (amended)	$28.22B+19%	233	SEC ↗
Q1 2020	May 12, 2020	$23.77B−21%	232	SEC ↗
Q4 2019	Feb 7, 2020	$30.15B+17%	238	SEC ↗
Q3 2019	Nov 14, 2019	$25.69B−2%	235	SEC ↗
Q2 2019	Jul 30, 2019	$26.28B+4%	265	SEC ↗
Q1 2019	Apr 24, 2019	$25.24B+9%	271	SEC ↗
Q4 2018	Feb 8, 2019	$23.19B−13%	283	SEC ↗
Q3 2018	Nov 13, 2018	$26.80B+33%	274	SEC ↗
Q2 2018	Aug 10, 2018	$20.13B+8%	259	SEC ↗
Q1 2018	May 14, 2018	$18.67B−23%	238	SEC ↗
Q4 2017	Feb 13, 2018	$24.34B+7%	306	SEC ↗
Q3 2017	Nov 13, 2017	$22.78B+8%	308	SEC ↗
Q2 2017	Aug 11, 2017	$21.00B+4%	311	SEC ↗
Q1 2017	May 12, 2017	$20.25B+6%	308	SEC ↗
Q4 2016	Feb 10, 2017	$19.15B−7%	305	SEC ↗
Q3 2016	Nov 14, 2016	$20.53B+6%	300	SEC ↗
Q2 2016	Aug 12, 2016	$19.33B+5%	291	SEC ↗
Q1 2016	May 12, 2016	$18.49B	303	SEC ↗